October 2016

VariantWire Adds New Members to its Data-sharing Network
The GeneInsight-powered platform advances molecular informatics initiatives

TUCSON, Ariz., October 13, 2016

Sunquest Information Systems Inc. today announced that Nationwide Children’s

Hospital Institute for Genomic Medicine Clinical Laboratory, MedComp Sciences

and the University of Minnesota Health Fairview are now members of the

VariantWire® data sharing initiative.

Read More

April 2016

Sunquest Acquires GeneInsight to Enhance Precision Medicine Capabilities
Transaction advances Sunquest’s clinical genetics IT platform

Tucson, Ariz. – April 4, 2016 – Sunquest Information Systems Inc. today announced the acquisition of GeneInsight Inc., an IT company that streamlines the analysis, interpretation and reporting of complex genetic tests.

Read More

November 2015

Cellnetix Selects GeneInsight to Support Complex Cancer Testing
Software will support next generation sequencing panels to identify more targeted treatments for tumor types

Sunquest Information Systems Inc., and Partners HealthCare today announced that CellNetix Pathology and Laboratories has selected GeneInsight to streamline and enhance their somatic testing program

Read More

October 2015

GeneInsight to Improve Genetic Testing for Cancer
Relationship with Brigham and Women’s Hospital will allow for integration of comprehensive cancer content to aid genetic test interpretation

GeneInsight Inc. today announced a relationship with Brigham and Women’s Hospital (BWH) to integrate high-quality cancer content with GeneInsight functionality to make complex genetic test interpretation easier and more accessible to laboratories everywhere.

Read More

October 2015

Sunquest Information Systems and Partners HealthCare Announce New Features to Advance Genome and Exome Testing
Release extends filtration, annotation and storage capabilities for complex genetic data

Sunquest Information Systems Inc. and Partners HealthCare today announced the general availability of a new version of GeneInsight, a genetic information solution, to extend the system’s report generation and knowledge management capabilities to exome and genome testing. 

Read More

September 2014

Sunquest Information Systems and Partners HealthCare Announce Strategic Alliance
Sunquest and GeneInsight will collaborate on providing seamless genetic testing workflow capabilities to clinical geneticists and pathologists

Sunquest Information Systems and Partners HealthCare are establishing a strategic alliance to accelerate genomic-based medicine. The relationship involves a strategic investment by Sunquest into GeneInsight, Inc., an IT platform company that streamlines the analysis, interpretation, and reporting of complex genetic test results. Sunquest and Partners have a shared vision for clinical genomics, with the goal of developing a next generation genomic information system and knowledgebase that will speed the advent of precision medicine.​

Read More

March 2014

GeneInsight Promotes Information Sharing to Advance Personalized Medicine
VariantWire to Improve Collaboration and Data Sharing

Partners HealthCare and GeneInsight® announced that a clinical consortium, originally piloted in 2013, is now actively sharing data in real time, offering clinical laboratories across the U.S. and Canada the opportunity to access information that can ultimately help to advance the field of personalized medicine.  GeneInsight, which supports reporting and knowledge management for genetic testing laboratories, is enabling this secure data sharing and collaboration among participant members through a ‘share and share alike’ networking philosophy.

Read More

June 2013

GeneInsight: Genetic Knowledge to Action

Bio-It World recently featured an article highlighting the development and growth of the GeneInsight suite of applications. GeneInsight was recently awarded the 2013 Bio-IT World Best Practices Editor’s Prize.

 

Read More

May 2013

CollabRx and GeneInsight to Collaborate on Interpretation and Reporting Service for Clinical Genetic Sequencing

San Francisco, CA and Boston, MA, May 8, 2013 (GLOBE NEWSWIRE)  – CollabRx, Inc. (NASDAQ: CLRX), a data analytics company focused on informing the clinical interpretation of molecular diagnostic testing, and GeneInsight LLC., a leading developer of software to support knowledge management and reporting for genetic testing laboratories, today announced an agreement to deliver a unique medical informatics solution to support the interpretation and reporting of genetic variants from sequencing-based tests.  ​

Read More

April 2013

Partners Subsidiary GeneInsight Launches Network to Enable Data Sharing Between Clinical Labs

Genomeweb recently featured an article on GeneInsight’s data sharing network. The GeneInsight Network is intended to help genetic testing labs keep abreast of new information about genetic variants’ significance and provide interpretive reports to clinicians that help them select optimal treatments for their patients.

Read More

April 2013

Partners HealthCare and GeneInsight Earn the 2013 Editors’ Choice Award for Technology Innovation in the Life Sciences

Bio-IT World Editors’ Choice Award presented to Partners HealthCare Center for Personalized Genetic Medicine (PCPGM) for the GeneInsight Suite®, at its ninth Best Practices Awards program following the opening keynote at the 2013 Bio-IT World Conference & Expo.

Read More

March 2013

Ingenuity Systems and GeneInsight to Deliver an Interpretation and Reporting Workflow Solution to Clinical Laboratories

REDWOOD CITY, CA and BOSTON, MA – (PR NEWSWIRE) – March 19, 2013 - Ingenuity® Systems, a leading provider of biomedical information and genomics analysis solutions, and GeneInsight®, a wholly owned subsidiary of Partners HealthCare and a leading developer of software to support reporting for genetic testing laboratories, today announced that they will collaborate on an integrated workflow solution, encompassing the annotation, analysis, assessment and reporting of human variants from sequencing-based tests. The ability to provide the clinical laboratory market with a seamlessly integrated workflow to support next generation sequencing-based tests takes a significant step forward with this collaboration.

Read More

January 2013

Partners HealthCare and Illumina Announce Founding Members of GeneInsight Network
Providing Medical Geneticists and Pathologists with Infrastructure and Networking Tools to Support the Clinical Interpretation and Reporting Process

BOSTON and SAN DIEGO—(BUSINESS WIRE)—January 7, 2013—Partners HealthCare and Illumina, Inc. (NASDAQ:ILMN) today announced the GeneInsight-Illumina Founding Network Members, including the ARUP Laboratories,  Mount Sinai Genetic Testing Laboratory, New York Genome Center (NYGC), Partners HealthCare, and Illumina. The members represent a diverse and distinguished group of laboratories within leading academic institutions and commercial organizations who are interested in leveraging clinical-grade genomics interpretation and reporting. The members are committed to exploring and sharing knowledge, including variant level content and interpretations, through the formation of inter-laboratory collaborations and “knowledge rings.” The network will be opened widely later in 2013 to other institutions willing to share clinical genomic data.

Read More

December 2012

Partners to Offer Whole Genome Sequencing Service, GeneInsight Suite® will Support Clinical Interpretation and Reporting Process for New Service
Partners’ Lab for Molecular Medicine, led by chief laboratory director Heidi L. Rehm, has developed more than 150 genetic tests.

The Boston Globe recently featured an article about the Partners HealthCare Center for Personalized Genetic Medicine and the opportunity that whole genome sequencing brings for the treatment of disease. Starting in January, Partners HealthCare Center for Personalized Genetic Medicine (PCPGM) will be offering whole genome sequencing, one of only ten facilities nationwide to offer this service. GeneInsight Suite®, developed at Partners, will be an integral part of streamlining the analysis, interpretation, and reporting of the whole genome sequencing service.

Read More

November 2012

GeneInsight’s Clinical Interpretation and Reporting Solution Used as the Model for the Winning Team of Boston Children’s Hospital International Genomics Competition

A multi‐institution team led by the Brigham and Women’s Hospital Division of Genetics wins the CLARITY Challenge for best interpretation and communication of DNA sequencing results. Reports generated through GeneInsight were utilized as the model for “the very best clinical report” within the contest.

Read More

October 2012

Illumina’s Highly Anticipated ‘Understand Your Genome’ Symposium Supported by GeneInsight Interpretation and Reporting Tool

Illumina hosted their first ‘Understand Your Genome’ event in October, a unique symposium that provided industry professionals and leaders an opportunity to have their genomes sequenced and analyzed. The interpretation and report generation for the event was done in collaboration with GeneInsight.

Read More

September 2012

Illumina Launches TruSightTM Targeted Sequencing Content Sets
Expert-Designed Content Enables Labs to Realize Benefits of Next-Generation Sequencing

SAN DIEGO—(BUSINESS WIRE)—Sep. 11, 2012— Illumina, Inc. (NASDAQ:ILMN) today announced five initial TruSight content sets for use in next-generation sequencing (NGS) in laboratory settings. Designed by recognized experts at leading institutions, the content sets offer cost-effective, streamlined, targeted sequencing for specific genetic diseases or conditions. Customers can immediately leverage this content to develop their own tests, and in the first half of 2013 will have the additional capability to augment the sets with custom content.

Read More

September 2012

Illumina and Partners HealthCare Announce Alliance to Introduce Next-Generation Sequencing Clinical Interpretation and Reporting Tools
Leaders in Sequencing and Patient Care Team Up to Offer New Tools for Genetic Test Reporting

SAN DIEGO & BOSTON—(BUSINESS WIRE)—Sep. 11, 2012— Illumina, Inc. (NASDAQ:ILMN) and Partners HealthCare today announced a strategic alliance to offer medical geneticists and pathologists infrastructure and networking tools to support the interpretation and reporting process for genetic sequencing data. The tools will integrate the functionality of Illumina’s MiSeq® sequencing system and Partners GeneInsight Suite®, an IT platform that streamlines the analysis, interpretation, and reporting of complex genetic test results. The GeneInsight Suite is registered with the FDA as a Class I exempt medical device.

Read More